Design, Synthesis, and Biological Evaluation of Lipid‐Modified Derivatives of Tunicamycins
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202502296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Kazuki Yamamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan. Hauptthemen laut MEDLINE: Tunicamycin, Anti-Bacterial Agents, Bacterial Proteins, Transferases. Die Arbeit nennt 30 Literaturangaben. Gefördert von: AMED, JSPS, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Naturally occurring antibiotic tunicamycin targets bacterial peptidoglycan biosynthesis by inhibiting bacterial phospho‐ N ‐acetylmuraminic acid (MurNAc)‐pentapeptide translocase (MraY), but it also inhibits human UDP‐ N ‐acetylglucosamine (GlcNAc): polyprenol phosphate translocase (GPT), leading to cytotoxicity. This study thoroughly investigated the structure‐activity relationship of the fatty acyl side chain of tunicamycin to develop MraY‐selective inhibitors, based on structural differences between MraY and GPT. Longer alkyl chains and flexible structures were found to favor MraY inhibitory activity, and benzene rings were acceptable for binding. The hybrid analogue containing oleoyl group, which contributed most significantly to MraY inhibitory activity, and the MurNAc moiety, which is important for MraY‐selective inhibition, showed enhanced MraY inhibitory activity as well as improved antibacterial activity against S. aureus and E. faecium .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
- Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
- Laboratory of Veterinary Hygiene, School/Faculty of Veterinary Medicine, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo, 060-0818, Japan.
- Graduate School of Infectious Diseases, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo, 060-0818, Japan.
- One Health Research Center, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo, 060-0818, Japan.
- Department of Biochemistry, Duke University Medical Center, Durham, NC, USA.
ORCID-Profile: Satoshi Ichikawa
Förderung
- AMED
- JSPS
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Yamamoto, K., Sato, T., Mashalidis, E. H., Lee, S. Y., Horiuchi, M., & Ichikawa, S. (2025). Design, Synthesis, and Biological Evaluation of Lipid‐Modified Derivatives of Tunicamycins. Chemistry – A European Journal. https://doi.org/10.1002/chem.202502296
Vancouver
Yamamoto K, Sato T, Mashalidis EH, Lee SY, Horiuchi M, Ichikawa S. Design, Synthesis, and Biological Evaluation of Lipid‐Modified Derivatives of Tunicamycins. Chemistry – A European Journal. 2025. doi:10.1002/chem.202502296
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Kazuki and Sato, Toyotaka and Mashalidis, Ellene H and Lee, Seok-Yong and Horiuchi, Motohiro and Ichikawa, Satoshi},
title = {Design, Synthesis, and Biological Evaluation of Lipid‐Modified Derivatives of Tunicamycins},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202502296}
}
EUVIMED